Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S (MAL019)
This study has been completed.
Sponsor:
U.S. Army Office of the Surgeon General
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
Walter Reed Army Institute of Research (WRAIR) ( U.S. Army Office of the Surgeon General )
ClinicalTrials.gov Identifier:
NCT01556945
First received: March 14, 2012
Last updated: March 16, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | February 2002 (Final data collection date for primary outcome measure) |